News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1931 results

WHO plans to vaccinate Africa with Moderna COVID vaccine hit stumbling block

Africa16-09-2021Ben Wodecki

Just 12 African countries have hit WHO’s 10% vaccination target as supply chain issues worsen.

Intel backs Mylan's anti-Fintiv SCOTUS stance

US16-09-2021Muireann Bolger

Intel has backed Mylan's bid to convince the US Supreme Court to remove the controversial NHK-Fintiv rule, on the basis that it is “unlawful”.

Bausch settles $300m antitrust case over diabetes drug price hikes

US13-09-2021Ben Wodecki

Canadian pharma firm Bausch Health has agreed to settle an antitrust suit where it was accused of holding an illegal monopoly on the diabetes drug Glumetza.

Australia backs COVID-19 vaccine waiver

Australia09-09-2021Muireann Bolger

Australia will waive IP protections for COVID-19 vaccines to enable more cost-effective copycat versions to be manufactured in developing countries, in the wake of mounting pressure from human rights groups and governments worldwide.

Teva drops lawsuit with Amicus over Creates Act dispute

US07-09-2021Muireann Bolger

Teva Pharmaceuticals has abandoned its lawsuit against Amicus Therapeutics, which it had accused of contravening a US federal law designed to help generic makers bring cost-effective biosimilars to market.

BMS, Pfizer win patent dispute over blockbuster drug, Eliquis

US06-09-2021Muireann Bolger

In a victory for Bristol-Myers Squibb and Pfizer, the US Court of Appeals for the Federal Circuit has affirmed the validity of a pair of patents covering blood clot treatment, Eliquis.

Mylan, Edwards back NHK-Fintiv challenge

US31-08-2021Alex Baldwin

Mylan Pharmaceutical and Edwards Lifesciences have joined a petition urging the US Supreme Court to order the US Court of Appeals for the Federal Circuit to reconsider inter partes review petitions that have been denied due to the NHK-Fintiv rule.

South Korea asks US for access to vaccine IP

South Korea, US31-08-2021Alex Baldwin

South Korean officials have urged the US government to help Korean companies gain access to IP related to producing COVID-19 jabs.

Fed Circ written description ruling overturns $1.2 billion award

US26-08-2021Alex Baldwin

Kite Pharma has successfully persuaded the US Court of Appeals for the Federal Circuit to reverse a $1.2 billion win for the Bristol-Meyers Squibb owned Juno Therapeutics over a cancer treatment patent.

Regeneron asks court to dismiss COVID-19 tech patent suit

US24-08-2021Alex Baldwin

Regeneron wants a Manhattan district court to toss a lawsuit that claims it infringed on patents in the development and testing of COVID-19 treatments.

Showing 1 to 10 of 1931 results

LSIPR